Abstract Urothelium-specific overexpression of nerve growth factor (NGF) in the urinary bladder of transgenic mice stimulates neuronal sprouting or proliferation in the urinary bladder, produces urinary bladder hyperreflexia, and results in increased referred somatic hypersensitivity. Additional NGF-mediated changes might contribute to the urinary bladder hyperreflexia and pelvic hypersensitivity observed in these transgenic mice such as upregulation of neuropeptide/receptor systems. Chronic overexpression of NGF in the urothelium was achieved through the use of a highly urothelium-specific, uroplakin II promoter. In the present study, we examined pituitary adenylate cyclase activating polypeptide (PACAP), vasoactive intestinal polypeptide (VIP), and associated receptor (PAC1, VPAC1, VPAC2) transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral dorsal root ganglia in NGF-overexpressing and littermate wildtype mice using real-time quantitative reverse transcriptionpolymerase chain reaction and immunohistochemical approaches. Results demonstrate upregulation of PAC1 receptor transcript and PAC1-immunoreactivity in urothelium of NGF-OE mice whereas PACAP transcript and PACAP-immunoreactivity were decreased in urothelium of NGF-OE mice. In contrast, VPAC1 receptor transcript was decreased in both urothelium and detrusor smooth muscle of NGF-OE mice. VIP transcript expression and immunostaining was not altered in urinary bladder of NGF-OE mice. Changes in PACAP, VIP, and associated receptor transcripts and protein expression in micturition pathways resemble some, but not all, changes observed after induction of urinary bladder inflammation known to involve NGF production.
Introduction
We recently examined the role of nerve growth factor (NGF) in urinary bladder dysfunction by generating a mouse model of urinary bladder hypersensitivity based on the hypothesis that chronic urothelial NGF overexpression would induce sensory neuronal hypersensitivity and increased urinary bladder reflex function (Schnegelsberg et al. 2010) . Chronic overexpressing of NGF in the urothelium was achieved through the use of a highly urotheliumspecific, uroplakin II promoter (Lin et al. 1995; Liang et al. 2005) . Our studies (Schnegelsberg et al. 2010 ) revealed that urothelium-specific overexpression of NGF in the urinary bladder of transgenic mice (1) stimulates neuronal sprouting or proliferation in the urinary bladder, (2) produces local inflammatory changes in the urinary bladder, (3) produces urinary bladder hyperreflexia, and (4) results in increased referred somatic hypersensitivity. Additional NGF-mediated changes might contribute to the urinary bladder hyperreflexia and pelvic hypersensitivity observed in these mice (Schnegelsberg et al. 2010) , such as stimulation/recruitment of bladder mast cells, modulation of local neuroinflammatory responses, or upregulation of neuropeptides and ion channels. NGF-mediated changes in the excitability and/or sensitization of primary afferents (Nicol and Vasko 2007 ) is likely to involve changes in expression of nociception-related molecules, including sensory neuropeptides (Vizzard 2000c (Vizzard , 2001 Braas et al. 2006; de Groat and Yoshimura 2009 ).
Many studies have suggested the involvement of the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP) in lower urinary tract (LUT) function after bladder inflammation (Vizzard 2000c; Braas et al. 2006; Herrera et al. 2006 ) and in nociception (Sandor et al. 2009 ). PACAP is a member of the vasoactive intestinal polypeptide (VIP), secretin, glucagon family of hormones and exhibits ∼68% homology to VIP (Arimura 1992) . PACAP can act on three types of G protein-coupled receptors including VPAC1 and VPAC2 that respond to PACAP and VIP whereas PAC1 is a specific receptor for PACAP (Arimura 1998; Sherwood et al. 2000; Vaudry et al. 2000) . PACAP-immunoreactive sensory neurons and fibers are found in micturition pathways and upregulated with urinary bladder inflammation induced by cyclophosphamide (CYP) treatment (Vizzard 2000c; Fahrenkrug and Hannibal 1998; Mohammed et al. 2002; Braas et al. 2006) . We have demonstrated specific PACAP receptor expression in bladder smooth muscle, urothelium, lumbosacral dorsal root ganglia (DRG), and spinal cord suggesting that PACAP and PAC1 receptor signaling participate at multiple levels in the lower urinary tract consistent with the direct effects of PACAP and VIP in other smooth muscle systems (Schworer et al. 1993; Steenstrup et al. 1994; Linden et al. 1999; Fizanne et al. 2004) . Many previous studies in rodents have demonstrated the importance of NGF in bladder sensory function and the development of referred hyperalgesia in response to bladder inflammation (Jaggar et al. 1999; Zvara and Vizzard 2007; Guerios et al. 2008; Arms et al. 2009 ). In the present study, we examined PACAP, VIP, and associated receptor transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral DRG in NGFoverexpressing (OE) and littermate wildtype mice using real-time quantitative reverse transcription-polymerase chain reaction (Q-PCR) and immunohistochemical approaches.
Materials and Methods

Animals
NGF-OE transgenic mice were generated at Roche Palo Alto (material transfer agreement with Roche Palo Alto and Dr. Debra Cockayne) in collaboration with Dr. Henry Sun at the New York University Medical School as previously described (Cheppudira et al. 2008; Schnegelsberg et al. 2010) . Animal genotype was confirmed by Southern and/or PCR analyses; all mice have the inbred genetic C57BL/6J background and were derived from F2 to F4 generations maintained through a hemizygous backcross strategy with C57BL/6J wildtype mice. Female mice used in this study were bred locally at The University of Vermont College of Medicine. The litters were of normal size and weight and behaviors (feeding, drinking, activity patterns) appeared normal. All experimental protocols involving animal use were approved by the University of Vermont Institutional Animal Care and Use Committee (IACUC # 08-085). Animal care was under the supervision of the University of Vermont's Office of Animal Care Management in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and National Institutes of Health guidelines. All efforts were made to minimize the potential for animal pain, stress, or distress.
Measurement of Urinary Bladder NGF by Enzyme-Linked Immunoassay
Determination of NGF content in the urinary bladder and DRG (L1-S1) of NGF-OE transgenic mice and WT littermate controls was determined using enzyme-linked immunoassays (ELISAs) as previously described (Vizzard 2000b; Cheppudira et al. 2008; Schnegelsberg et al. 2010) . Microtiter plates (R & D Systems, Minneapolis, MN, USA) were coated with a mouse anti-rat NGF antibody (R & D Systems, Minneapolis, MN). Sample and standard solutions were run in duplicate. A horseradish peroxidase-streptavidin conjugate was used to detect the antibody complex. Tetramethyl benzidine was the substrate and the enzyme activity was measured by the change in optical density. The NGF standard provided with this protocol generated a linear standard curve from 15 to 1,000 pg/ml (R 2 =0.998, p≤0.0001) for tissue samples. The absorbance values of standards and samples were corrected by subtraction of the background absorbance due to nonspecific binding. No samples fell below the minimum detection limits of the assay and no samples were diluted prior to use. Curve fitting of standards and evaluation of NGF content of samples was performed using a least squares fit as previously described (Vizzard 2000b; Schnegelsberg et al. 2010 ).
Euthanasia and Tissue Harvest
Wildtype (WT) and NGE-OE littermate (n=5-7 for each; 5-6 weeks of age) mice were deeply anesthetized with isoflurane (3-4%) and then euthanized via thoracotomy. The urinary bladder and lumbosacral DRG were quickly dissected under RNase-free conditions. The bladder was cut open along the midline and pinned to a sylgard-coated dish, the urothelium was removed with the aid of fine forceps and a dissecting microscope, and all tissues were snapfrozen on dry ice prior to processing as previously described Arms et al. 2009 ). The urothelium has suburothelial structures associated with it; the term urothelium in this paper refers to both urothelial and suburothelial structures. DRG were identified and isolated as previously described (Vizzard 1997 (Vizzard , 2000a . Lumbosacral DRG (L6, S1) were specifically chosen for real-time Q-PCR analysis based upon the previously determined segmental representation of urinary bladder circuitry (Donovan et al. 1983; Keast and de Groat 1992; Nadelhaft and Vera 1995) . Bladder afferents are not distributed within the L4-L5 DRG (Donovan et al. 1983; Keast and de Groat 1992 ) that contain only somatic afferents nor are neurons that are involved in urinary bladder function observed in the L4-L5 spinal segments (Nadelhaft and Vera 1995) . Harvest of DRG was restricted to L6-S1 because previous studies have demonstrated the presence of PAC1 and VPAC2 receptors in these tissues using nonquantitative reverse-transcription polymerase chain reaction ).
Real-Time Quantitative Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted using the STAT-60 total RNA/ messenger RNA (mRNA) isolation reagent (Tel-Test'B', Friendswood, TX, USA) as previously described (Girard et al. 2002; . One to 2 mg of RNA per sample (urinary bladder or DRG) was used to synthesize complementary DNA using SuperScript II reverse transcriptase and a mix of random hexamer and oligo dT primers with the SuperScript II Preamplification System (Invitrogen, Carlsbad, CA, USA) in a 20-ml final reaction volume.
The quantitative PCR standards for all transcripts were prepared with the amplified PAC1, VPAC1, VPAC2, PACAP, VIP, NGF, and 18S complementary DNA products ligated directly into pCR2.1 TOPO vector using the TOPO TA cloning kit (Invitrogen). The nucleotide sequences of the inserts were verified by automated fluorescent dideoxy dye terminator sequencing (Vermont Cancer Center DNA Analysis Facility). To estimate the relative expression of the receptor transcripts, tenfold serial dilutions of stock plasmids were prepared as quantitative standards. The range of standard concentrations was determined empirically.
Real-time quantitative PCR was performed using SYBR Green I detection (Girard et al. 2002; Arms et al. 2009 ). Complementary DNA templates, diluted fivefold to minimize the inhibitory effects of the reverse transcription reaction components, were assayed using SYBR Green I JumpStart TM . Taq ReadyMix TM (Sigma, St. Louis, MO, USA) contains 5 mM MgCl 2 ; 200 mM dATP, dGTP, dCTP, and dTTP; 0.64 U Taq DNA polymerase; and 300 nM of each primer in a final 25-ml reaction volume. The real-time quantitative PCR was performed on an Applied Biosystems 7500 Fast real-time PCR system (Applied Biosystems, Foster City, CA, USA) (Girard et al. 2002; Arms et al. 2009 ) using the following standard conditions: (1) serial heating at 50°C for 2 min and 94°C for 2 min; (2) amplification over 40 cycles at 94°C for 15 s and 60 to 64°C depending on primers set for 40 s.
The amplified product from these amplification parameters was subjected to SYBR Green I melting analysis by ramping the temperature of the reaction samples from 60°C to 95°C. A single DNA melting profile was observed under these dissociation assay conditions demonstrating amplification of a single unique product free of primer dimers or other anomalous products. Oligonucleotide primer sequences for PACAP (Girard et al. 2002) , VIP (Girard et al. 2002) , PAC1 (Braas and May 1999) , VPAC1 (Girard et al. 2006) , VPAC2 (Girard et al. 2006) , NGF (Schnegelsberg et al. 2010) , and 18S (Girard et al. 2002; used in these studies have been previously described.
For data analyses, a standard curve was constructed by amplification of serially diluted plasmids containing the target sequence. Data were analyzed at the termination of each assay using the Sequence Detection Software version 1.3.1 (Applied Biosystems, Norwalk, CT, USA). In standard assays, default baseline settings were selected. The increase in SYBR Green I fluorescence intensity (DRn) was plotted as a function of cycle number and the threshold cycle was determined by the software as the amplification cycle at which the DRn first intersects the established baseline. All data are expressed as the relative quantity of the gene of interest normalized to the relative quantity of the housekeeping gene 18S. WT samples are set equal to 100%.
Immunohistochemistry
Bladder cryosections (10 µm) from wildtype (n=5) and NGF-OE (n=5) mice were prepared for immunohistochemistry using an on-slide processing technique Arms et al. 2009 ). For immunohistochemical processing, the cryosections were incubated overnight at room temperature with rabbit anti-PAC 1 (1:2,000) (Braas and May 1999) , rabbit anti-PACAP (1:500; Bachem Americas, Inc., Torrance, CA, USA) or rabbit anti-VIP (1:1,000; Immunostar, Inc., Hudson, WI, USA) diluted in 0.1 M potassium phosphate-buffered saline containing 1% goat serum. After washing, the preparations were incubated with a Cy3-conjugated species-specific secondary antibody (1:500) for 2 h at room temperature, rinsed, and mounted with antifade medium (Citifluor Ltd., London, UK) for fluorescent microscopy. Methodological and procedural controls were performed including preabsorption of PAC1, PACAP, or VIP antisera with appropriate immunogen (1-3 µg/ml) that reduced staining to background levels.
Visualization and Semi-quantitative Analysis of PAC1, PACAP, or VIP in Urothelium PAC1, PACAP, or VIP staining in bladder sections was visualized and images were captured using an Olympus fluorescence photomicroscope. The filter was set with an excitation range of 560-569 nm and emission range of 610-655 nm for visualization of Cy3. Images were captured, acquired in tiff format, and imported into Meta Morph image analysis software (version 4.5r4; University Imaging, Downingtown, PA, USA) Arms et al. 2009 ). The free hand drawing tool was used to select the urothelium and the urothelium was measured in total pixels area Arms et al. 2009) . A threshold encompassing an intensity range of 100-250 grayscale values was applied to the region of interest in the least brightly stained condition first. The threshold was adjusted for each experimental series using concomitantly processed negative controls as a guide for setting background fluorescence. The same threshold was subsequently used for all images. Immunoreactivity was considered to be positive only when the staining for the marker of interest (PAC1, PACAP, VIP) exceeded the established threshold. Percent marker expression above threshold in the total area selected was calculated.
Visualization and Semi-quantitative Analysis of PAC1, PACAP, or VIP in Detrusor Smooth Muscle
Visualization of PAC1, PACAP, and VIP-IR in detrusor smooth muscle of cryostat sections was identical to that described for the urothelium (above). Semi-quantification of PAC1, PACAP, or VIP-IR in detrusor smooth muscle was performed as previously described (Klinger et al. 2007; Cheppudira et al. 2008 ) and modified from Brady et al. (2004) . Grayscale images acquired in tiff format were imported into Image J (Abramoff et al. 2004 ) and images were thresholded. Images of detrusor smooth muscle were acquired from the dome, body, and neck region of the urinary bladder in WT and NGF-OE mice. A rectangle of fixed dimension (500×500 pixels) was placed on the section according to a random selection of x and y coordinates. This process was repeated seven times for each image of detrusor. The average optical density of PAC1, PACAP, or VIP-IR in detrusor smooth muscle was then calculated. PAC1, PACAP, and VIP-IR in the detrusor exhibited equivocal expression throughout detrusor of the dome, body, and neck of the urinary bladder; thus, data from each region are pooled and presented as PAC1, PACAP, or VIP-IR in detrusor smooth muscle.
Digital images were obtained using a CCD camera (MagnaFire SP; Optronics; Optical Analysis Corp., Nashua, NH, USA) and LG-3 frame grabber (Scion Corp, Frederick, MD, USA). Exposure times, brightness, and contrast were held constant when acquiring images from experimental or control animals processed and analyzed on the same day. 
Statistical Analyses
One-way analysis of variance was used to evaluate differences among groups for Q-PCR. Percentage data from image analysis were arcsin-transformed to meet the requirements of this statistical test. Animals, processed and analyzed on the same day, were tested as a block in the ANOVA. Differences were considered statistically significant if p≤0.05. When F ratios exceeded the critical value (p≤0.05), the Newman-Keul's post hoc test was used to compare the experimental means.
Results
NGF Expression in Urothelium, Detrusor, and Lumbosacral DRG of WT and NGF-OE Mice Consistent with our previous studies (Cheppudira et al. 2008; Schnegelsberg et al. 2010) , NGF transcript and protein expression was significantly (p≤0.01) increased in urothelium of NGF-OE mice; no changes were observed in detrusor smooth muscle between NGF-OE and littermate WT mice (data not shown). Similarly, no changes in NGF transcript were detected in any DRG level examined (L1-S1) between NGF-OE and littermate WT mice (data not shown).
PAC1, VPAC1, and VPAC2 Receptor Transcript Expression in Urothelium and Detrusor of WT and NGE-OE Mice
Consistent with previous studies in rats Girard et al. 2008 ), PAC1, VPAC1, and VPAC2 receptor transcripts were expressed in the urothelium and detrusor smooth muscle of mouse urinary bladder (Fig. 1a-c) . In urothelium of NGF-OE mice, PAC1 receptor transcript exhibited a significant (p≤0.05) increase in expression whereas no changes were exhibited in detrusor smooth muscle between wildtype (WT) and NGF-OE mice (Fig. 1a) . PAC1 receptor transcript expression was also significantly greater in detrusor smooth muscle compared to urothelium in both WT and NGF-OE mice (Fig. 1a) . In urothelium and detrusor smooth muscle of NGF-OE mice, VPAC1 receptor transcript expression was significantly (p≤0.01) decreased compared to WT Figure 2 PAC1-immunoreactivity in urothelium (U) (a-c) and detrusor smooth muscle (sm) (d-e) of littermate wildtype (WT) and NGF-overexpressing (NGF-OE) mice. Faint PAC1-IR was present in apical urothelial cells of WT urothelium (a, arrows). In NGF-OE mice, PAC1-IR was increased in apical urothelial cells (b-c, arrows) but was also expressed in all urothelial cell layers (b, bracket). PAC1-IR was expressed in detrusor smooth muscle of WT and NGF-OE mice (d-e). f Summary histogram of PAC1 expression in the U and detrusor sm in WT and NGF-OE mice. Values are mean ± SEM; n=5. *p≤0.01. L lumen. Calibration bar equals 50 μm with no changes in receptor transcript expression observed between tissues (urothelium vs. detrusor) (Fig. 1b) . In detrusor smooth muscle of NGF-OE mice, VPAC2 receptor transcript expression was significantly (p≤0.01) increased whereas no changes were observed in the urothelium or between detrusor and urothelium in WT and NGF-OE mice (Fig. 1c) .
PAC1-Immunoreactivity (IR) in Urothelium and Detrusor of WT and NGE-OE Mice
Changes in PAC1-IR in tissue sections paralleled changes in PAC1 receptor transcript expression. PAC1-IR was significantly increased in urothelium of NGF-OE compared to WT (Fig. 2a-c, f) . PAC1-IR was observed in WT urothelium, primarily in apical cells, consistent with previous demonstrations of PAC1-IR in rat urothelium . In urothelium of NGF-OE mice, PAC1-IR was increased in apical urothelial cells (Fig. 2b, c) and PAC1-IR was also observed in other urothelial layers (intermediate and basal) . No changes in PAC1-IR were observed in detrusor smooth muscle between WT and NGF-OE mice (Fig. 2d-f ).
PACAP and VIP Transcript Expression in Urothelium and Detrusor of WT and NGE-OE Mice PACAP transcript expression significantly (p ≤ 0.05) decreased in the urothelium of NGF-OE mice compared to WT (Fig. 3a) . PACAP transcript expression was significantly (p≤0.05) greater in detrusor smooth muscle compared to urothelium in both WT and NGF-OE mice (Fig. 3a) . No changes in VIP transcript expression were detected in urothelium or detrusor of WT or NGF-OE mice (Fig. 3b) . However, VIP transcript expression was significantly (p ≤ 0.01) greater in detrusor smooth muscle compared to urothelium in both WT and NGF-OE mice (Fig. 3b) . 
PACAP and VIP-Immunoreactivity (IR) in Urothelium and Detrusor of WT and NGE-OE Mice
Changes in PACAP-IR in tissue sections paralleled changes in PACAP receptor transcript expression. PACAP-IR was significantly (p≤0.01) decreased in urothelium of NGF-OE compared to WT (Fig. 4a-c) . PACAP-IR was observed in WT urothelium in all cell layers (apical, intermediate, and basal) (Fig. 4a, arrows) . Some evidence of PACAP-IR in putative suburothelial nerves was also observed in WT mice (Fig. 4a) . In urothelium of NGF-OE mice, PACAP-IR was decreased throughout the urothelium (Fig. 4b) . No changes in PACAP-IR were observed in detrusor smooth muscle between WT and NGF-OE mice (Fig. 4c) . No changes in VIP-IR were observed in urothelium or detrusor smooth muscle in WT and NGF-OE mice (Fig. 5a-d) . In urothelium from WT and NGF-OE mice, VIP-IR was expressed throughout all urothelial cell layers (Fig. 5a, b) . VIP-IR in putative suburothelial nerves was observed in urinary bladder sections from both WT and NGF-OE mice (Fig. 5a -c, arrows) consistent with previous studies (Fahrenkrug and Hannibal 1998; Lasanen et al. 1992 ).
PAC1, VPAC1, and VPAC2 Receptor Transcript Expression in L6-S1 Dorsal Root Ganglia of WT and NGE-OE Mice Consistent with previous rat studies Girard et al. 2008 ), PAC1, VPAC1, and VPAC2 receptor transcripts are expressed in mouse lumbosacral (L6-S1) DRG (data not shown). No changes in PAC1, VPAC1, or VPAC2 receptor transcript expression were observed between WT and NGF-OE mice or between L6 and S1 DRG (data not shown).
PACAP and VIP in L6-S1 Dorsal Root Ganglia of WT and NGE-OE Mice No changes in PACAP or VIP transcript expression were observed between WT and NGF-OE mice in L6 or S1 DRG (Fig. 6a, b) . In S1 DRG, PACAP transcript expression was significantly greater in both WT and NGF-OE mice compared to L6 levels (Fig. 6a) . In S1 DRG, VIP transcript expression was significantly greater in WT mice compared to L6 levels (Fig. 6b) . 
Discussion
We examined PACAP, VIP, and associated receptor (PAC1, VPAC1, VPAC2) transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral DRG in NGF-overexpressing (OE) and littermate wildtype mice using real-time quantitative reverse transcriptionpolymerase chain reaction and immunohistochemical approaches. PAC1 receptor transcript and PAC1-immunoreactivity was significantly increased in urothelium of NGF-OE mice whereas PACAP transcript and PACAPimmunoreactivity were decreased in urothelium of NGF-OE mice. In contrast, VPAC1 receptor transcript was decreased in both urothelium and detrusor smooth muscle of NGF-OE mice. VPAC2 receptor transcript was significantly increased in the detrusor smooth muscle in NGF-OE mice. VIP transcript expression and immunostaining was not altered in urinary bladder of NGF-OE mice. Changes in PACAP, VIP, and associated receptor transcripts and protein expression in micturition pathways resemble some, but not all, changes observed after induction of urinary bladder inflammation known to involve NGF production (Oddiah et al. 1998; Vizzard 2000b; Bjorling et al. 2001; Dupont et al. 2001; Murray et al. 2004; Guerios et al. 2008; .
Increased urinary bladder NGF content may underlie many of the sensory changes that occur in patients with OAB symptoms or interstitial cystitis/bladder pain syndrome (IC/BPS), including irritative voiding symptoms and pain in the case of IC/BPS (Okragly et al. 1999; Kim et al. 2005 Kim et al. , 2006 Liu and Kuo 2007; Liu and Kuo 2008a, b) . Altered NGF content is associated with urinary bladder inflammation and dysfunction in rodents (Vizzard 2001; Zvarova et al. 2004; Braas et al. 2006; Schnegelsberg et al. 2010) . IC/BPS is a chronic inflammatory bladder disease of unknown etiology characterized by urinary frequency, urgency, and suprapubic/ pelvic pain (Driscoll and Teichman 2001; Sant and Hanno 2001) . Pain and altered bladder/visceral hypersensitivity in IC/BPS patients may involve organizational or functional changes in peripheral bladder afferents and central pathways such that bladder afferent neurons become sensitized and hyperresponsive to normally innocuous stimuli such as bladder filling (Driscoll and Teichman 2001; Sant and Hanno 2001) . A few studies have demonstrated increased innervation of the bladder suburothelial and detrusor layers by PGP9.5-positive, substance P-positive, or sympathetic nerve fibers in IC/BPS patients (Christmas et al. 1990; Lundeberg et al. 1993; Hoyle et al. 1998; Peeker et al. 2000) . In NGF-OE mice, there was a marked increase in the density of CGRP-and substance P-positive C-fiber sensory afferents, neurofilament 200 (NF200) myelinated sensory afferents, and tyrosine hydroxylase-positive sympathetic nerve fibers within the suburothelial nerve plexus of the urinary bladder (Schnegelsberg et al. 2010) . In this study, we have begun to determine whether chronic NGF-OE in the urothelium causes additional neurochemical changes in expression of PACAP, VIP, and associated receptors (PAC1, VPAC1, VPAC2) in the urinary bladder and lumbosacral DRG that might contribute to the bladder hyperreflexia and pelvic hypersensitivity in NGF-OE mice.
PACAP peptides have diverse functions in the endocrine, nervous, gastrointestinal, and cardiovascular systems (Braas and May 1996; Arimura 1998) and differential effects on nociception (Sandor et al. 2009 ) through PAC1, VPAC1, and VPAC2 G protein-coupled receptors. High levels of PACAP and VIP expression have been identified in many central nervous system neurons and in sensory and autonomic ganglia (Arimura et al. 1991; Sundler et al. 1996; Moller et al. 1997a, b; Arimura 1998; Braas et al. 1998) . Both PACAPand VIP-immunoreactivity have been identified in urinary bladder (Fahrenkrug and Hannibal 1998; Mohammed et al. 2002) . PACAP and VIP peptides regulate smooth muscle function, either directly or by facilitating cholinergic and nitric oxide mechanisms, in a tissue-and species-specific manner (Mizumoto et al. 1992; Onaga et al. 1998 ; Fox- Threlkeld et al. 1999; Seebeck et al. 2002; Zizzo et al. 2004) . A number of studies have implicated PACAP in lower urinary tract function (Vizzard 2000c; Braas et al. 2006; Herrera et al. 2006) .
In the present study using mice with chronic overexpression of NGF in the urothelium, we have demonstrated increased PAC1 receptor transcript expression and immunostaining in the urothelium. These data are consistent with previous studies demonstrating that NGF increases PAC1 mRNA levels in rat PC12 cells (Jamen et al. 2000; Jamen et al. 2002) and that reduced PAC1 receptor mRNA expression is present in NGF null embryos (Andres et al. 2008) . In this study, VPAC1 receptor transcript expression was reduced in both the urothelium and detrusor smooth muscle in NGF-OE mice, and no changes in VPAC2 receptor transcript expression were observed in either urothelium or detrusor in NGF-OE mice. PACAP transcript expression and immunostaining was decreased in urothelium of NGF-OE mice whereas VIP transcript expression and immunostaining was not altered in urinary bladder of NGF-OE mice. In contrast, enhanced target-derived NGF availability has been shown to increase PACAP expression in small nociceptive neurons in DRG (Vizzard 2000c; Jongsma Wallin et al. 2001 , 2003 . In experimental inflammation paradigms, the expression of several sensory peptides including PACAP is increased while VIP levels, by contrast, are unchanged (Donaldson et al. 1992; Lu et al. 2005 ). NGF does not increase VIP expression in DRG that may be consistent with the target tissue neurotrophic model to selectively augment PACAP expression in DRG (Mulderry and Lindsay 1990; V. May and K. Braas, unpublished observations) . Although many studies have demonstrated similarities in receptors and channels expressed and neurochemical properties between urothelial cells and DRG cells (Birder 2005; Birder 2006; Birder 2009 ), the present study demonstrates differences in NGF regulation of PACAP expression between these cell types.
VPAC1 and VPAC2 receptor transcript expression was differentially affected in detrusor smooth muscle of NGF-OE mice. VPAC1 receptor transcript expression was reduced whereas VPAC2 receptor expression was increased in detrusor smooth muscle in NGF-OE mice. Changes in transcript expression in detrusor in mice with chronic overexpression of NGF in the urothelium suggest urothelial-mesenchymal interactions whereby urothelial NGF expression may influence detrusor smooth muscle properties as previously demonstrated for development and differentiation of detrusor smooth muscle (Liu et al. 2000; Baskin et al. 2001) . In contrast to observed changes in VIP/PACAP and receptor systems in the urinary bladder of NGF-OE mice, no changes were observed in lumbosacral (L6-S1) DRG of NGF-OE mice. This was not surprising given the absence of increased NGF content in these DRG as demonstrated with ELISAs and suggests absence of retrograde NGF transport from urinary bladder to DRG in these mice.
It is clear from the present studies that chronic overexpression of NGF in the urothelium results in some, but not all, of the same changes in VIP, PACAP, and receptor transcript or protein expression in micturition pathways demonstrated in rodent models of CYP-induced bladder inflammation (Vizzard 2000c; Girard et al. 2008) . We have previously demonstrated involvement of many chemical mediators (e.g., neurotrophins, cytokines, chemokines, neuropeptides) produced in micturition reflex pathways with cystitis that may underlie changes in neurochemical (Vizzard 2001; Zvarova et al. 2004; Braas et al. 2006; , organizational (Vizzard 1999 (Vizzard , 2000b ) and electrophysiological (Yoshimura and de Groat 1999) properties of micturition pathways and referred somatic sensitivity (Guerios et al. 2006; Guerios et al. 2008) . Although changes in PAC1 receptor transcript and protein in NGF-OE mice paralleled changes observed in the rodent model of CYP-induced cystitis, VPAC1, VPAC2, and PACAP transcript and protein expression did not change or changed in an opposite manner compared to the CYP-induced bladder inflammation model. These results suggest that chemical mediators upregulated with CYP-induced bladder inflammation other than or in addition to NGF (e.g., neurotrophins (Vizzard 2000b) , cytokines (Malley and Vizzard 2002) , chemokines (Yuridullah et al. 2006; Arms et al. 2009 ), neuropeptides (Vizzard 2001; Braas et al. 2006 )) contribute to altered VPAC1, VPAC2, and PACAP transcript and protein expression in micturition pathways following CYP-induced cystitis. Given the increased PAC1 receptor transcript and protein expression in urothelium of NGF-OE mice, current studies are addressing the contribution of PACAP/PAC1 signaling to demonstrated bladder hyperreflexia and referred pelvic hypersensitivity in NGF-OE mice (Schnegelsberg et al. 2010) .
